newsfilter
← Latest News
GlobeNewswire·

ContraFect Reports First Quarter 2022 Financial Results and Provides Business Update

YONKERS, N.Y., May 16, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (NASDAQ:CFRX), a late clinical-stage biotechnology company focused on the discovery and development of direct lytic agents (DLAs), including lysins and amurin peptides, as new medic